Redmile Group, Llc's Net Worth
Redmile Group, Llc's net worth is estimated to be at least $246,033,327.31 as of 12/23/2024. CoreStreet's estimation of Redmile Group, Llc's net worth is based on their sale of stock and current holding of stock.
Redmile Group, Llc is Major Shareholder at ADC Therapeutics SA. They have executed at least 28 trades of stock as per SEC Form 4 filings. Their most recent trade was for 100,000 units of ADCT stock on 12/11/2024. Their biggest sale was on 09/28/2016 when they sold 2,492,578 units of Array Technologies Inc stock for $15,852,796.08. They typically trade 3 times per year.
Total value of insider buys:
- $230,128,052.59
Total value of insider sells:
- $15,905,274.72
Most recent insider trade:
- Dec. 11, 2024
Redmile Group, Llc's Insider Trading History
| ADC Therapeutics SA | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 11, 2024 | Major Shareholder | 100,000 | $3.04 | Buy | $304,000.00 |
Dec. 4, 2024 | Major Shareholder | 25,352 | $2.07 | Sell | $52,478.64 |
July 1, 2024 | Major Shareholder | 400,000 | $2.81 | Buy | $1,124,000.00 |
| Shattuck Labs Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 4, 2024 | Director | 133,371 | $1.25 | Buy | $166,713.75 |
Oct. 14, 2020 | Director | 3,441,176 | $17.34 | Buy | $59,669,991.84 |
| Absci Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 1, 2024 | Director | 222,222 | $4.50 | Buy | $999,999.00 |
| Fate Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 26, 2023 | Director | 44,630 | $3.72 | Buy | $166,023.60 |
April 20, 2023 | Director | 20,000 | $5.99 | Buy | $119,800.00 |
April 14, 2023 | Director | 25,700 | $6.00 | Buy | $154,200.00 |
Jan. 8, 2021 | Director | 327,485 | $85.50 | Buy | $27,999,967.50 |
June 11, 2020 | Director | 1,412,928 | $28.31 | Buy | $39,999,991.68 |
Sept. 16, 2019 | Director | 857,143 | $17.50 | Buy | $15,000,002.50 |
Sept. 25, 2018 | Director | 3,703,704 | $13.50 | Buy | $50,000,004.00 |
| IGM Biosciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 8, 2020 | Director | 47,113 | $49.91 | Buy | $2,351,409.83 |
Sept. 3, 2020 | Director | 74,253 | $48.69 | Buy | $3,615,378.57 |
Sept. 1, 2020 | Director | 41,759 | $44.84 | Buy | $1,872,473.56 |
| Neoleukin Therapeutics | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 2, 2020 | Major Shareholder | 39,300 | $11.37 | Buy | $446,841.00 |
March 30, 2020 | Major Shareholder | 32,500 | $9.94 | Buy | $323,050.00 |
March 27, 2020 | Major Shareholder | 50,000 | $9.21 | Buy | $460,500.00 |
| Array Technologies Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 28, 2016 | Major Shareholder | 2,492,578 | $6.36 | Sell | $15,852,796.08 |
Sept. 15, 2016 | Major Shareholder | 400,000 | $3.51 | Buy | $1,404,000.00 |
Jan. 20, 2016 | Major Shareholder | 300,000 | $3.19 | Buy | $957,000.00 |
Jan. 12, 2016 | Major Shareholder | 75,000 | $3.60 | Buy | $270,000.00 |
Jan. 11, 2016 | Major Shareholder | 925,000 | $3.67 | Buy | $3,394,750.00 |
Oct. 1, 2015 | Major Shareholder | 782,592 | $4.58 | Buy | $3,584,271.36 |
Aug. 25, 2015 | Major Shareholder | 790,000 | $5.38 | Buy | $4,250,200.00 |
Aug. 10, 2015 | Major Shareholder | 1,048,993 | $5.80 | Buy | $6,084,159.40 |
| Syros Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 6, 2016 | Major Shareholder | 432,746 | $12.50 | Buy | $5,409,325.00 |